共 24 条
[3]
Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial
[J].
Neurology and Therapy,
2023, 12
:2007-2019
[6]
Sustained response of galcanezumab in migraine prevention: Patient--level data from a post hoc analysis in patients with episodic or chronic migraine
[J].
HEADACHE,
2023, 63 (10)
:1380-1390
[7]
Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
[J].
JOURNAL OF CLINICAL NEUROLOGY,
2023, 19 (05)
:483-494
[10]
Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study
[J].
HEADACHE,
2020, 60 (10)
:2444-2453